This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2001 Feb 15;344(7):520-2.

doi: 10.1056/NEJM200102153440710.

Should patients with drug-resistant HIV-1 continue to receive antiretroviral therapy?

L M Frenkel, J I Mullins

PMID: 11172196
DOI: 10.1056/NEJM200102153440710

Editorial

Should patients with drug-resistant HIV-1 continue to receive antiretroviral therapy?

L M Frenkel et al. N Engl J Med. 2001.

. 2001 Feb 15;344(7):520-2.

doi: 10.1056/NEJM200102153440710.

Authors

L M Frenkel, J I Mullins

PMID: 11172196
DOI: 10.1056/NEJM200102153440710

No abstract available

PubMed Disclaimer

Comment on

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.
Deeks SG, Wrin T, Liegler T, Hoh R, Hayden M, Barbour JD, Hellmann NS, Petropoulos CJ, McCune JM, Hellerstein MK, Grant RM. Deeks SG, et al. N Engl J Med. 2001 Feb 15;344(7):472-80. doi: 10.1056/NEJM200102153440702. N Engl J Med. 2001. PMID: 11172188 Clinical Trial.

Similar articles

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.
Deeks SG, Wrin T, Liegler T, Hoh R, Hayden M, Barbour JD, Hellmann NS, Petropoulos CJ, McCune JM, Hellerstein MK, Grant RM. Deeks SG, et al. N Engl J Med. 2001 Feb 15;344(7):472-80. doi: 10.1056/NEJM200102153440702. N Engl J Med. 2001. PMID: 11172188 Clinical Trial.
[Viral dynamics in the course of HIV-1 infection: pathogenetic features and new therapeutic prospects].
Marcello A, Giacca M. Marcello A, et al. Pathologica. 2000 Aug;92(4):291-3. Pathologica. 2000. PMID: 11029891 Italian. No abstract available.
Antiretroviral resistance.
Geretti AM. Geretti AM. J HIV Ther. 2006 Dec;11(4):72-3. J HIV Ther. 2006. PMID: 17578209 No abstract available.
[Monitoring anti-retroviral treatment].
Miró JM, Pumarola T, Soriano V, Bouza E. Miró JM, et al. Enferm Infecc Microbiol Clin. 1996 Oct;14 Suppl 1:44-50. Enferm Infecc Microbiol Clin. 1996. PMID: 9053027 Review. Spanish. No abstract available.
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K. Van Vaerenbergh K. Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.

See all similar articles

Cited by

[Study of factors related to adherence to antiretroviral therapy among patients followed at HIV/AIDS Unit in the District Hospital of Dschang, Cameroon].
Mbopi-Kéou FX, Dempouo Djomassi L, Monebenimp F. Mbopi-Kéou FX, et al. Pan Afr Med J. 2012;12:55. Epub 2012 Jun 29. Pan Afr Med J. 2012. PMID: 22937195 Free PMC article. French.
A cost-effectiveness analysis of alternative HIV retesting strategies in sub-saharan Africa.
Waters RC, Ostermann J, Reeves TD, Masnick MF, Thielman NM, Bartlett JA, Crump JA. Waters RC, et al. J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):443-52. doi: 10.1097/QAI.0b013e3182118f8c. J Acquir Immune Defic Syndr. 2011. PMID: 21297484 Free PMC article.
Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults.
Barbour JD, Wrin T, Grant RM, Martin JN, Segal MR, Petropoulos CJ, Deeks SG. Barbour JD, et al. J Virol. 2002 Nov;76(21):11104-12. doi: 10.1128/jvi.76.21.11104-11112.2002. J Virol. 2002. PMID: 12368352 Free PMC article.
Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host.
Herbeck JT, Nickle DC, Learn GH, Gottlieb GS, Curlin ME, Heath L, Mullins JI. Herbeck JT, et al. J Virol. 2006 Feb;80(4):1637-44. doi: 10.1128/JVI.80.4.1637-1644.2006. J Virol. 2006. PMID: 16439520 Free PMC article.
Adaptation of HIV-1 depends on the host-cell environment.
van Opijnen T, de Ronde A, Boerlijst MC, Berkhout B. van Opijnen T, et al. PLoS One. 2007 Mar 7;2(3):e271. doi: 10.1371/journal.pone.0000271. PLoS One. 2007. PMID: 17342205 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information